4/A

PRIMARY DOCUMENT

Company: UNITED THERAPEUTICS Corp
Filed: October 27, 2015
Period of Report: October 19, 2015
Accession Number: 0001127602-15-029618

View Document ↗ View on SEC.gov ↗